A proposal to redefine familial combined hyperlipidaemia – Third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the Scientific Sessions of the European Society for Clinical Investigation
- 1 February 2002
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 32 (2) , 71-73
- https://doi.org/10.1046/j.1365-2362.2002.00941.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemiaAtherosclerosis, 2000
- Defects of lipoprotein metabolism in familial combined hyperlipidaemiaCurrent Opinion in Lipidology, 1998
- Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)The American Journal of Cardiology, 1995
- International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference MaterialClinical Chemistry, 1994
- Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIAJournal of Clinical Investigation, 1973
- FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASEThe Lancet, 1973
- Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotypeThe American Journal of Medicine, 1973